Insiders · Profile

Murray Dallan

Chief Customer Officer at Sarepta Therapeutics. Filing since 2 May 2024. CIK 0002022303

Company

Date

Role

Action

Amount

Of holding

2 May 2024

Chief Customer Officer

Sold on a plan

3,635

$508.90K

16.7%

1 decision on file.